Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

PerkinElmer To Purchase Remaining Interest Of Mass Spectrometry Joint Venture

PerkinElmer has agreed to purchase the remaining interest of its joint venture in Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and related assets from Danaher Corporation (Danaher). Danaher has acquired this joint venture stake and assets as part of its acquisition of MDS’ Analytical Technologies business.

ICP-MS is a detection technology that allows simultaneous detection of individual chemical elements in a sample, for diverse applications within the environmental, nutraceutical, biomonitoring, semiconductor and geochemical research markets.

PerkinElmer said that the purchase of the remaining 50% of the joint venture and related assets will provide the company with full ownership of the joint venture and its ICP-MS product line. Complete PerkinElmer ownership of the ICP-MS product line and related assets will help to ensure the continued success of this technology with a dedicated and fully integrated approach throughout the entire value chain, including R&D, manufacturing, sales and service.

John Roush, president of environmental health at PerkinElmer, said: “Our continued commitment and innovation in ICP-MS will provide our customers with solutions that support the analysis of component elements, trace elements or contaminants in samples of interest, leading to improved products and applications for their end markets – and ultimately to better outcomes for human and environmental health.

“The consolidation of the joint venture will reinforce our market leadership position while further demonstrating our commitment to the ICP-MS product line and the sustained development of this critical technology. Customers will benefit from our ability to get products to market faster, as well as to better align our offering with market needs.”